The project is born out of a concrete demand within the pharma supply chain to provide a hi-tech solution to tackle the problem of limited-supply and out-of-stock medicine.
The “Self Sovereign Identity” (SSI) digital-identity model may provide a lasting solution to the often spurtive and indiscriminate sharing of our personal information. How might this innovation become incorporated into Italian and European regulations?
The partnership will allow both companies to deliver digitally-enhanced services all along the customer journey, from awareness to conversion and even post-sale.